The integration of artificial intelligence into radiology departments across the UK represents one of healthcare’s most significant technological shifts, yet it arrives with a complex web of medico-legal challenges that clinicians, trusts, and regulators are still working to untangle.
Responsibility when AI-assisted diagnosis fails
At the heart of these challenges lies a fundamental question: who bears responsibility when AI-assisted diagnosis goes wrong? Traditional medical negligence in the UK operates under the Bolam principle, which requires a doctor to exercise the standard of care expected of a reasonably competent practitioner. However, AI introduces an intermediary that doesn’t fit neatly into established legal frameworks. When a radiologist relies on an AI system that fails to flag a pulmonary nodule or misclassifies a stroke, determining liability becomes significantly more nuanced.
Current guidance from bodies like the Royal College of Radiologists emphasises that clinical responsibility remains firmly with the reporting radiologist. AI tools are positioned as decision-support systems rather than autonomous diagnosticians, meaning radiologists cannot simply defer to algorithmic outputs. This creates a challenging dynamic: radiologists must maintain vigilance over AI recommendations while simultaneously managing increasing workloads that AI was partly introduced to alleviate.
Risks and legal implications of using AI in the medico-legal context
The medico-legal risk emerges when radiologists either over-rely on AI, missing errors the system makes, or under-utilise it, potentially facing questions about why available technology wasn’t employed.
The UK’s regulatory environment adds another layer of complexity. AI software used in diagnostic radiology must comply with the Medical Devices Regulations 2002 and carry a CE or UKCA marking. The Medicines and Healthcare products Regulatory Agency (MHRA) oversees this, but the pace of AI development often outstrips regulatory adaptation. Software that learns and evolves post-deployment raises particular concerns: if an algorithm’s performance changes after initial validation, at what point does it require re-certification? When performance drift occurs, who monitors it, and what are the legal implications of continued use?
How is data protection affected by using Artificial Intelligence (AI)?
Data protection represents yet another medico-legal minefield. AI systems require vast datasets for training and validation, raising questions under the UK GDPR and the Data Protection Act 2018. NHS trusts must ensure patient data used for AI development is processed lawfully, with appropriate safeguards and, where necessary, consent. The sharing of imaging data across institutions or with commercial AI developers requires robust data-sharing agreements and clear governance structures. Breaches could expose trusts to significant legal action and regulatory penalties from the Information Commissioner’s Office.
Documentation and consent present practical challenges. Should radiologists document which AI tools were used in their reporting process? If AI influenced clinical decision-making, does this information belong in the medical record? For certain screening applications, do patients require specific consent to have their images analysed by AI? These questions lack clear precedents, leaving trusts to develop their own policies while hoping they withstand future legal scrutiny.
The future of AI for a Radiology expert witness
Looking forward, the medico-legal framework will need to evolve alongside the technology. Professional indemnity insurers are beginning to grapple with AI-related claims, but coverage terms remain unclear in many scenarios. As AI moves from assistive to potentially autonomous roles in specific radiology tasks, the UK may need to consider new liability models, possibly including manufacturer liability or even AI-specific insurance schemes.
For now, radiologists and their employing trusts must proceed with careful risk management: maintaining robust validation and audit processes, ensuring clear lines of clinical responsibility, documenting AI use appropriately, and staying informed about evolving regulatory requirements. The promise of AI in radiology is substantial, but navigating its medico-legal implications requires as much attention as optimising its clinical performance.
If you are interested in instructing Dr Shouvik Saha, please get in touch with our dedicated enquiries team at enquiries@mlas.co.uk or visit his profile, where you can view his CV